These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34728332)

  • 1. Characterization of a Novel Implant Intended to Expand and Reshape the Prostatic Urethra for the Treatment of Benign Prostatic Hyperplasia: A Pre-Clinical Feasibility Study in the Canine Model.
    Chughtai B; Punyala A; Lata SS; Maul DH; Cho A; Stanley J; Rouselle S; Gonzalez RR
    Urology; 2022 Jan; 159():167-175. PubMed ID: 34728332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Huang CP; Huang WJ; Chang YH; Lien CS; Chkhotua A; Elterman DS
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):576-582. PubMed ID: 35641601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective multi-center study elucidating patient experience after prostatic urethral lift.
    Shore N; Freedman S; Gange S; Moseley W; Heron S; Tutrone R; Brown T; Barkin J
    Can J Urol; 2014 Feb; 21(1):7094-101. PubMed ID: 24529008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift.
    McVary KT; Gange SN; Shore ND; Bolton DM; Cowan BE; Brown BT; Te AE; Chin PT; Rukstalis DB; Roehrborn CG;
    J Sex Med; 2014 Jan; 11(1):279-87. PubMed ID: 24119101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia.
    Vjaters E; Nitsan D; Mullerad M; Engelstein D; Leibovitch I; Feld Y
    Eur Urol Focus; 2020 Jan; 6(1):131-136. PubMed ID: 30293945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Chin PT; McNicholas TA; Gill HS; Plante MK; Bruskewitz RC; Roehrborn CG
    BJU Int; 2011 Jul; 108(1):82-8. PubMed ID: 21554526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates.
    Yoon CJ; Song HY; Kim JH; Park HG; Kang HS; Ro JY; Hong JH
    J Vasc Interv Radiol; 2010 Sep; 21(9):1429-35. PubMed ID: 20688535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of temporary covered nitinol stent placement in the prostatic urethra: short-term study in the canine model.
    Crisóstomo V; Song HY; Maynar M; Sun F; Soria F; Lima JR; Yoon CJ; Usón-Gargallo J
    Cardiovasc Intervent Radiol; 2007; 30(4):731-7. PubMed ID: 17436035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction.
    Roehrborn CG; Chin PT; Woo HH
    Prostate Cancer Prostatic Dis; 2022 Mar; 25(1):79-85. PubMed ID: 34363010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Chin PT; Bolton DM; Jack G; Rashid P; Thavaseelan J; Yu RJ; Roehrborn CG; Woo HH
    Urology; 2012 Jan; 79(1):5-11. PubMed ID: 22202539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Safety and Efficacy of the ClearRing™ Implant for the Treatment of Benign Prostatic Hyperplasia in a Canine Model.
    Feld Y; Golan S; Leibovitch I
    Curr Urol; 2018 Jun; 11(4):206-211. PubMed ID: 29997464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic Urethral Lift: A New Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
    Bozkurt A; Karabakan M; Keskin E; Hirik E; Balci MB; Nuhoglu B
    Urol Int; 2016; 96(2):202-6. PubMed ID: 26613256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Woo HH; Bolton DM; Laborde E; Jack G; Chin PT; Rashid P; Thavaseelan J; McVary KT
    J Sex Med; 2012 Feb; 9(2):568-75. PubMed ID: 22172161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the histological response to the Butterfly Prostatic Retraction Device in patients with benign prostatic hyperplasia.
    Katz R; Sze C; Punyala A; Ahmed MA; Safadi A; Roizman S; Zisman A; Aharoni S; Baniel J; Chughtai B
    World J Urol; 2023 Apr; 41(4):1141-1146. PubMed ID: 36797501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Year follow-up of temporary implantable nitinol device implantation for the treatment of benign prostatic obstruction.
    Porpiglia F; Fiori C; Bertolo R; Giordano A; Checcucci E; Garrou D; Cattaneo G; De Luca S; Amparore D
    BJU Int; 2018 Jul; 122(1):106-112. PubMed ID: 29359881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covered retrievable prostatic urethral stents: feasibility study in a canine model.
    Yoon CJ; Song HY; Shin JH; Woo CW; Ro JY; Park HK; Yoon HK
    J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1813-9. PubMed ID: 17142712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.